"The health and safety of our patients, visitors, employees, and our communities remain a top priority at NewYork-Presbyterian. In response to the evolving COVID-19 outbreak and in line with our revised General Visitation Guidelines, we are keeping select entrances open at each Hospital throughout the enterprise. All other entrances will be closed and inaccessible to patients, visitors, and staff. The following entrances will remain open for patients, visitors, and employees: Main and Emergency Department Entrances"

During the past decade, New York Presbyterian Allen Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York Presbyterian Allen Hospital" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Medicem International CR s.r.o." with 1 trials as a collaborator and "National Institute of Nursing Research (NINR)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "New York Presbyterian Allen Hospital" are "Aortocaval Compression" (1 trials), "Cesarean Delivery" (1 trials), "Degenerative Disc Disease" (1 trials), "Fetal Acidosis" (1 trials) and "Hospital Acquired Condition" (1 trials). Many other conditions were trialed in "New York Presbyterian Allen Hospital" in a lesser frequency.

Most popular intervention types in "New York Presbyterian Allen Hospital" are "Procedure" (2 trials), "Behavioral" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CONCERN CDS system notification" (1 trials), "Dilapan" (1 trials), "Misoprostol" (1 trials), "Oblique Lateral Interbody Fusion" (1 trials) and "SUPINE" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Presbyterian Allen Hospital" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "New York Presbyterian Allen Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in New York Presbyterian Allen Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New York Presbyterian Allen Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".